Related Experiment Video
Updated: Oct 10, 2026

In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
Basic Concepts of (Myocardial) Angiogenesis: Role of Vascular Endothelial Growth Factor and Angiopoietin
1The Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, KU Leuven, Leuven, B-3000, Belgium.
Insights
This review explores how the body forms new blood vessels (angiogenesis) and enlarges existing ones (arteriogenesis) to improve heart blood flow during ischemia. Understanding these processes, particularly the roles of vascular endothelial growth factor (VEGF) and angiopoietin (Ang), is key for developing new heart therapies.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Regenerative Medicine
Background:
- Blood vessels supply oxygen and nutrients to the heart, crucial for function.
- Ischemia, caused by blocked arteries, triggers compensatory blood vessel growth (angiogenesis and arteriogenesis).
- Understanding molecular mechanisms of angiogenesis is vital for therapeutic strategies.
Purpose of the Study:
- To review the roles of vascular endothelial growth factor (VEGF) and angiopoietin (Ang) in angiogenesis.
- To discuss novel insights into hypoxia-driven regulation of angiogenesis.
- To present a new mouse model for studying ischemic cardiomyopathy and therapeutic angiogenesis.
Main Methods:
- Literature review of molecular mechanisms in angiogenesis and arteriogenesis.
- Discussion of hypoxia's role in regulating blood vessel formation.
- Presentation of a novel mouse model for ischemic cardiomyopathy.
Main Results:
- VEGF and Ang are key classes of angiogenic molecules.
- Hypoxia significantly regulates the process of angiogenesis.
- A new mouse model exhibiting ischemic cardiomyopathy and hibernation provides a platform for research.
Conclusions:
- Enhanced understanding of molecular pathways in angiogenesis is necessary for effective therapeutic design.
- Targeting VEGF and Ang pathways, alongside hypoxia regulation, holds promise for improving myocardial perfusion.
- The presented mouse model can advance research into therapeutic myocardial angiogenesis.
Abstract:
Blood vessels are essential for the supply of oxygen and nutrients to the heart. An imbalance between oxygen demand and supply (ischemia), as occurs when coronary arteries become obstructed by atherosclerotic plaques, triggers a response to improve myocardial perfusion by the formation of new capillaries (angiogenesis) and by the enlargement of preexisting collateral vessels (arteriogenesis). Recently, novel insights have been obtained in the molecular mechanisms of angiogenesis and in its control by hypoxia. This has lead to the design of strategies to improve myocardial perfusion. However, rational design of therapeutic angiogenesis mandates a better understanding of the molecular basis of angiogenesis. This review discusses the role of two prime classes of angiogenic molecules, namely of vascular endothelial growth factor (VEGF) and angiopoietin (Ang), and addresses novel insights in the regulation of angiogenesis by hypoxia. In addition, a novel mouse model of ischemic cardiomyopathy with signs of hibernation is presented. Possible implications for therapeutic myocardial angiogenesis are discussed.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Development of Blood Vessels
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...

